Loading...
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH
Long-acting reversible contraceptive methods — including the progestin implant and intrauterine devices (IUDs) — should be first-line contraceptive options for adolescents because of their safety, efficacy, and ease of use, according to a new policy statement from the American Academy of Pediatrics.
Among the other recommendations, published in Pediatrics:
Depot medroxyprogesterone acetate (DMPA) and the contraceptive patch are "highly effective" and "much safer than pregnancy" and, therefore, should still be made available to teens. (Concerns have been raised about DMPA's effects on bone health and the patch's potential association with venous thromboembolism.)
Pediatricians should be made aware that pelvic examinations are not necessary to prescribe contraceptives or refer patients for IUD placement.
Pediatric providers should reserve enough time with their adolescent patients to discuss contraceptive choices using a developmentally appropriate, individualized approach.
Eleanor Bimla Schwarz of NEJM Journal Watch Women's Health commented: "All leading medical organizations agree that subdermal and intrauterine contraceptives are the best options for teens. The good news is that placing subdermal contraception is quite easy. The challenge is that clinicians need to make time to complete the FDA-required training prior to being able to offer this to their patients."
Comment
LINK(S):
AAP policy statement in Pediatrics (Free PDF)
AAP technical report in Pediatrics (Free PDF)
Background: NEJM Journal Watch Women's Health summary on broader use of IUDs (Your NEJM Journal Watch registration required)